<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000537249"><TermName>maribavir</TermName><TermPronunciation>(mar-I-buh-veer)</TermPronunciation><TermDefinition><DefinitionText>A substance that blocks the ability of viruses to make new viruses and infect cells. It is being studied in the prevention of cytomegalovirus infection in cancer patients who have had a donor stem cell transplant. It is a type of antiviral agent.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000718239" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;maribavir&quot;" language="en" id="_3"/><MediaLink ref="CDR0000718238" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;maribavir&quot;" language="es" id="_4"/><SpanishTermName>maribavir</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia que impide que los virus produzcan nuevos virus e infecten células. Está en estudio para la prevención de la infección por citomegalovirus en pacientes que recibieron un trasplante de células madre de un donante. Es un tipo de antivírico.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2007-07-06</DateFirstPublished></GlossaryTerm>
